非金属对金属轴承THA因ARMD翻修的风险:澳大利亚国家关节置换登记研究
基于澳大利亚国家关节置换登记数据,分析现代非金属对金属轴承全髋关节置换术(THA)因金属碎屑不良反应(ARMD)翻修的累积风险。17年时现代轴承ARMD翻修累积百分比为0.1%,而大直径金属对金属轴承为15.5%;钴铬头、特定假体(Accolade I、M/L Taper)及头尺寸≥36 mm与翻修风险增加相关。
要点
- 现代非金属对金属轴承THA因ARMD翻修风险低,17年累积翻修率仅0.1%。
- 钴铬头、Accolade I和M/L Taper柄及头尺寸≥36 mm与ARMD翻修风险增加相关。
- 大直径金属对金属轴承ARMD翻修风险显著高于现代轴承(HR 340)。
核心结论
- 现代非金属对金属轴承THA因ARMD翻修风险低,但钴铬头、特定假体及头尺寸≥36 mm增加该风险。
研究设计与样本
- 基于澳大利亚骨科协会国家关节置换登记系统(AOANJRR)的纵向队列研究,纳入1999年9月至2018年12月期间因ARMD翻修的THA,排除模块化颈假体。
- 研究组包括350,027例现代轴承THA、15,184例大直径金属对金属轴承THA(≥36 mm)和5,474例小直径金属对金属轴承THA(≤32 mm)。
- 现代轴承组平均年龄68岁(SD 12),女性占55%;大直径金属对金属组平均年龄63岁(SD 12),女性占43%;小直径组平均年龄62岁(SD 11),女性占50%。
- 采用Kaplan-Meier估计计算17年因ARMD的累积翻修百分比(CPR),并用Cox比例风险模型(调整年龄和性别)比较组间翻修率。
主要发现
- 现代轴承THA因ARMD的17年CPR为0.1%(95% CI 0.0-0.1)。
- 大直径金属对金属轴承THA因ARMD的17年CPR为15.5%(95% CI 14.5-16.6),显著高于现代轴承(HR 340,95% CI 264.2-438.0;p < 0.001)。
- 小直径金属对金属轴承THA 0-9年因ARMD的CPR为0.9%(95% CI 0.7-1.4),高于现代轴承(HR 10.5,95% CI 6.2-17.7;p < 0.001)。
- 金属对交联聚乙烯(XLPE)因ARMD翻修风险高于陶瓷对陶瓷或陶瓷对XLPE(HR 3.4,95% CI 1.9-6.0;p < 0.001)。
- Accolade I柄(HR 8.3,95% CI 4.7-14.7;p < 0.001)和M/L Taper柄(HR 14.4,95% CI 6.0-34.6;p < 0.001)翻修风险高于其他柄;头尺寸≥36 mm的股骨柄翻修风险高于≤32 mm(HR 3.2,95% CI 1.9-5.3;p < 0.001)。
关键数值与推荐
- 现代轴承定义为金属或陶瓷头对XLPE以及陶瓷对陶瓷的轴承组合。
- 翻修定义为再次手术中替换或取出一个或多个假体组件,或增加一个或多个组件。
- 因ARMD翻修风险随假体因素变化:钴铬头、Accolade I和M/L Taper柄、头尺寸≥36 mm均与风险增加相关。
临床怎么用
- 对于现代非金属对金属轴承THA患者,ARMD是罕见失败模式,但出现不明原因疼痛且无其他明确原因时应考虑并进一步检查。
- 选择假体时需注意钴铬头、Accolade I和M/L Taper柄及头尺寸≥36 mm与ARMD翻修风险增加相关。
局限性
- 本研究为登记系统回顾性分析,证据等级为III级(治疗性研究)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are increasing reports of corrosion between the femoral head and trunnion in primary conventional THA, resulting in metal particulate release often termed trunnionosis. There may be heightened awareness of this condition because of severe soft-tissue reactions initially thought to be solely attributable to prostheses with a metal-on-metal (MoM) bearing surface. It is unclear what percentage of revisions for THA with non-MoM bearing surfaces can be attributed to trunnionosis and to what extent adverse reaction to metal debris (ARMD) seen with MoM bearings may also be seen with other bearing surfaces in THA. QUESTIONS/PURPOSES: We analyzed data from a large national registry to ask: (1) What is the revision risk for the indication of ARMD in patients with conventional THA and modern non-MoM bearing surfaces such as metal or ceramic-on-cross-linked polyethylene (XLPE) or ceramic-on-ceramic? (2) What prosthesis factors are associated with an increased risk of such revision? (3) What is the relative revision risk for ARMD in THAs with large-head MoM bearings, small-head MoM bearings, and non-MoM modern bearing surfaces? METHODS: The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) longitudinally maintains data on all primary and revision joint arthroplasties, with nearly 100% capture. The study population included all THAs using modern bearing surfaces (defined as metal or ceramic heads-on-XLPE and ceramic-on-ceramic bearing couples) revised because of ARMD between September 1999 and December 2018. Prostheses with modular necks were excluded. The cumulative percent revision (CPR) because of ARMD was determined. The study group consisted of 350,027 THAs with a modern bearing surface, 15,184 THAs with a large-head MoM bearing (≥ 36 mm), and 5474 THAs with a small head MoM bearing (≤ 32 mm). The patients in the group who received the modern bearing surfaces were slightly older than the patients in the groups who received the large- and small-head bearing surfaces, with a mean age 68 years (SD 12) versus a mean age 63 years (SD 12), and a mean age 62 years (SD 11), respectively. There was a higher proportion of women in the modern bearing surface group; 55% (193,312 of 350,027), compared with 43% (6497 of 15,184) in the large-head MoM group and 50% (2716 of 5474) in the small-head MoM group. The outcome measure was the CPR, which was defined using Kaplan-Meier estimates of survivorship to describe the time to the first revision for ARMD at 17 years. Hazard ratios (HR) from Cox proportional hazards models, adjusting for age and sex, were performed to compare the revision rates among groups. The registry defines a revision as a reoperation of a previous hip arthroplasty in which one or more of the prosthetic components is replaced or removed, or one or more components is added. RESULTS: The CPR for ARMD for patients with a modern bearing surface at 17 years was 0.1% (95% confidence interval 0.0 to 0.1). After controlling for age and sex, we found that cobalt chrome heads, two specific prostheses (Accolade® I and M/L Taper), and head sizes ≥ 36 mm were associated with an increased risk of revision for ARMD. Metal-on-XLPE had a higher risk of revision for ARMD than ceramic-on-ceramic or ceramic-on-XLPE (HR 3.4 [95% CI 1.9 to 6.0]; p < 0.001). The Accolade 1 and the M/L Taper stems had a higher risk of revision than all other stems (HR, 8.3 [95% CI 4.7 to 14.7]; p < 0.001 and HR 14.4 [95% CI 6.0 to 34.6]; p < 0.001, respectively). Femoral stems with head sizes ≥ 36 mm had a higher rate of revision for ARMD than stems with head sizes ≤ 32 mm (HR 3.2 [95% CI 1.9 to 5.3]; p < 0.001).Large-head MoM bearings had a greater increase in revision for ARMD compared with modern bearing surfaces. The CPR for patients with a large-head MoM bearing at 17 years for ARMD was 15.5% (95% CI 14.5 to 16.6) and it was 0.1% for modern bearing surfaces (HR 340 [95% CI 264.2 to 438.0]; p < 0.001). Modern bearing surfaces likewise had a lower HR for revision for ARMD than did THAs with small-head MoM bearings, which had a 0.9% (95% CI 0.7 to 1.4) CPR compared with modern bearings from 0 to 9 years (HR 10.5 [95% CI 6.2 to 17.7]; p < 0.001). CONCLUSIONS: The revision risk for ARMD with modern bearing surfaces in THA is low. The Accolade 1 and the M/L Taper stem have a higher risk of revision for ARMD and cobalt-chrome heads, and head sizes ≥ 36 mm have a higher rate of revision than ≤ 32 mm head sizes. ARMD is a rare failure mode for THA with non-MoM bearings, but in patients presenting with unexplained pain with no other obvious cause, this diagnosis should be considered and investigated further. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- de Steiger RN, Hatton A, Peng Y, et al. What Is the Risk of THA Revision for ARMD in Patients with Non-metal-on-metal Bearings? A Study from the Australian National Joint Replacement Registry. Clin Orthop Relat Res. 2020. PMID: 32345846. doi:10.1097/CORR.0000000000001277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。